Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2001 May;107(10):1215-8.
doi: 10.1172/JCI13038.

Can VEGF reverse diabetic neuropathy in human subjects?

A Veves  1 , G L King
Affiliations
Comment

Can VEGF reverse diabetic neuropathy in human subjects?

A Veves et al. J Clin Invest. 2001 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathogenesis of diabetic neuropathy. Factors implicated in the pathogenesis of diabetic neuropathy include the activation of the polyol pathway, the activation of protein kinase C (PKC), increased oxidative stress, the impaired N-6 fatty acid metabolism, auto-oxidation of glucose, the formation of advanced glycation end products (AGEs), and the reduced bioavailability of neurotrophic factors. All these mechanisms are interrelated and can potentiate each other’s detrimental effects. Although the exact mechanisms of their action are not well understood, it is currently believed that these factors lead to reduced Na+, K+ ATPase activity and vasoconstriction, reduced endoneurial blood flow and nerve hypoxia. The latter changes then lead to reduced nerve conduction velocities, axonal loss, axonal demyelination, and nerve dysfunction. DAG, diacylglycerol.
See this image and copyright information in PMC

Comment on

References

    1. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43:957–973. - PubMed
    1. Feldman EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clin Neurosci. 1997;4:365–370. - PubMed
    1. Pham HT, et al. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicentre trial. Diabetes Care. 2000;23:606–611. - PubMed
    1. Fagerberg SE. Diabetic neuropathy, a clinical and histological study on the significance of vascular affection. Acta Med Scand Suppl. 1959;345:1–97. - PubMed
    1. Tesfaye S, Malik RA, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia. 1994;37:847–854. - PubMed

Publication types

MeSH terms

Substances